A STUDY TO INVESTIGATE THE PREVALENCE OF METABOLIC SYNDROME IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

Dr Sachin Kumar Gupta, Dr Aashish Kumar Singh

Abstract


Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with several extra-pulmonary systemic manifestations including metabolic syndrome. Metabolic syndrome is an aggregate of inter-related cardio-metabolic risk factors, comprising glucose intolerance, abdominal obesity, dyslipidemia and hypertension, which are associated with an increased risk of cardiovascular disease and type-2 diabetes. The objective of study was to assess prevalence of metabolic syndrome among COPD patients.

Methods: This cross-sectional study was conducted from April 2017 to March 2018. Total 67 COPD patients were classified according to GOLD guideline. International Diabetes Federation (IDF) guideline was used for metabolic syndrome(MetS).

Results:  Prevalence of MetS was 29.85%, highest  (47.06%) in GOLD stage-II, followed by stage-I (40%).

Conclusions: The presence of metabolic syndrome is common in patients with COPD and all COPD patients should be considered for its screening.


Keywords


Chronic obstructive pulmonary disease, Metabolic syndrome

Full Text:

PDF

References


Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2017 report.

Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Pri Care Resp J. 2006 Apr 1;15(2):84-91.

Park SK, Larson JL. Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease. West J Nursing Res. 2014 May;36(5):620-42.

Poulain M, Doucet M, Drapeau V, Fournier G, Tremblay A, Poirier P, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chronic Resp Dis. 2008 Feb;5(1):35-41.

Tanni SE, Zamuner AT, Coelho LS, Vale SA, Godoy I, Paiva SA. Are metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pupmonary disease patients?. Metab Syndrome Related Disord. 2015 Feb 1;13(1):52-4.

Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Euro Res J. 2006 Feb 1;27(2):397-412.

Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J atheroscler thrombosis. 2005;12(6):295-300.

Henrik Watz, Benjamin Waschki, Anne Kirsten, Kai-Christian Mu¨ller; Gunther Kretschmar, Thorsten Meyer, Olaf Holz, HelgoMagnussen. The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD. 2009 CHEST; 136 (4):1039

Jesús Díez Manglano, José Barquero-Romero, Pedro Almagro, F. Javier Cabrera , Francisco López García, Lorena Montero, Joan B. Soriano. COPD patients with and without metabolic syndrome: clinical and functional differences. Internal and Emergncy Medicine. 2013;1-27

Karine Marquis, François Maltais, Véronique Duguay, Anne-Marie Bezeau, Picrre Le Blanc, Jcan Jobin, Paul Poirier. The Metabolic Syndrome in Patients With Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation. 2005;25:226-232

Emel Bulcun, Aydanur Ekici, Mehmet Ekici. Metabolic syndrome and chronic diseases in patients with chronic obstructive pulmonary disease. İzmir Göğüs Hospital journal.2015; 29:1-10

Z.Yasar, M. Buyuksirin, F.D. Ucsular, A.Kargi, F.Erdem, F. Talay, O.K. Kurt. Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patientswith chronic obstructive pulmonary disease? European Review for Medical and Pharmacological Sciences. 2015;19:956-962


Refbacks

  • There are currently no refbacks.